HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone marrow mesenchymal stromal cells with CD47 high expression via the signal transducer and activators of transcription signaling pathway preventing myocardial fibrosis.

AbstractUNLABELLED:
This study was initiated to investigate the efficacy of myocardial fibrosis intervention via signal transducer and activators of transcription (STAT) signaling using bone marrow (BM) mesenchymal stromal cells (MSC) in which being over-expressed with the aid of bispecific antibody (BiAb) and ultrasound-mediated microbubbles (MB). BiAb was prepared and combined with isolated MSC with CD47 overexpression from male mice and trans-fused into female mice with isoproterenol-induced myocardial fibrosis via the tail vein, followed by MB. This study included five groups. Five weeks after treatment, expression levels of the sex-determining region of Y-chromosome (SRY), matrix metalloproteinases (MMP)-9, tissue inhibitor of metalloproteinase (TIMP)-1 and vascular endothelial growth factor (VEGF) in myocardium were detected by fluorescent quantitative real-time polymerase chain reaction (qRT-PCR). The protein expression of signal transducer and activators of transcription (STAT) 1 and STAT 3 was detected by Western blot.
RESULTS:
The highest homing number of MSC was in the CD47 + MSC + BiAb + MB group, second highest in the CD47 + MSC + BiAb group, and lowest in MSC alone. Compared with the Control group, CD47 + MSC + BiAb + MB, CD47 + MSC + BiAb, CD47 + MSC and MSC groups had decreased levels of MMP-9, TIMP-1, STAT 1 and collagen deposition, and increased levels of STAT 3. Up regulated STAT 3 and down regulated TIMP-1 were significantly different in CD47 + MSC + BiAb + MB compared with CD47 + MSC or CD47 + MSC + BiAb.
CONCLUSION:
CD47 can enhance the homing rate and repairing efficacy of MSC. MSC can improve MMP-TIMP expression in injured myocardium and interfere with myocardial fibrosis after homing, a mechanism that may be related to the STAT-mediated signaling pathway.
AuthorsWei Deng, Qing-Wei Chen, Xing-Sheng Li, Zhong-Ming Yuan, Gui-Qiong Li, Da-Zhi Ke, Li Wang, Zhi-Qing Wu, Shi-Lan Luo
JournalInternational journal of clinical and experimental pathology (Int J Clin Exp Pathol) Vol. 8 Issue 9 Pg. 10555-64 ( 2015) ISSN: 1936-2625 [Electronic] United States
PMID26617765 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bispecific
  • CD47 Antigen
  • CD47 protein, rat
  • STAT1 Transcription Factor
  • STAT3 Transcription Factor
  • Sex-Determining Region Y Protein
  • Sry protein, rat
  • Stat1 protein, rat
  • Stat3 protein, rat
  • TIMP1 protein, rat
  • Tissue Inhibitor of Metalloproteinase-1
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Collagen
  • Matrix Metalloproteinase 9
  • Mmp9 protein, rat
  • Isoproterenol
Topics
  • Animals
  • Antibodies, Bispecific (immunology)
  • CD47 Antigen (genetics, metabolism)
  • Cardiomyopathies (chemically induced, genetics, immunology, metabolism, pathology, prevention & control)
  • Cells, Cultured
  • Collagen (metabolism)
  • Disease Models, Animal
  • Female
  • Fibrosis
  • Gene Expression Regulation
  • Isoproterenol
  • Male
  • Matrix Metalloproteinase 9 (genetics, metabolism)
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stem Cells (immunology, metabolism)
  • Myocardium (immunology, metabolism, pathology)
  • Phenotype
  • Rats, Sprague-Dawley
  • STAT1 Transcription Factor (metabolism)
  • STAT3 Transcription Factor (metabolism)
  • Sex-Determining Region Y Protein (genetics, metabolism)
  • Signal Transduction
  • Tissue Inhibitor of Metalloproteinase-1 (genetics, metabolism)
  • Transfection
  • Vascular Endothelial Growth Factor A (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: